Le Lézard
Classified in: Science and technology, Business
Subject: SVY

Adoption of Enterprise Performance Management Continues Upward Trend in 2024


Dresner Advisory Wisdom of Crowds Enterprise Performance Management Market Study Highlights User Trends

NASHUA, N.H., June 27, 2024 /PRNewswire/ -- Usage of enterprise performance management increased to 71 percent in 2024, up from 62 percent in 2023, according to the Dresner Advisory Services 2024 Wisdom of Crowds® Enterprise Performance Management Market Study. 

The Enterprise Performance Management (EPM) Market Study, now in its 10th edition, is Dresner's broad assessment of the market, providing a comprehensive look at key user behaviors, attitudes, and intentions and comparing the findings to previous years.

The report examines overall importance of EPM, adoption trends, implementation and sourcing strategies, planning priorities, and rolling forecasts. It includes an analysis of success with EPM, sourcing preferences, cloud deployments, as well as the impact of, and use cases for, artificial intelligence (AI).

Some of the report's findings include:

"New this year, our report explores the application of artificial intelligence (AI) to specific use cases within EPM. Although skepticism about AI in the context of EPM has been steadily dropping, barriers to adoption remain. Our analysis reveals where users see the greatest value for AI in supporting more effective performance management and decision making," said Howard Dresner, founder and chief research officer at Dresner Advisory.

The 2024 EPM Market Study includes a comprehensive analysis of the leading suppliers, ranking 16 vendors using four different models ? individual ratings using Dresner's trademark 33-measure system, and three collective models including a new Value / TCO Model.

Wisdom of Crowds® research is based on data collected on usage and deployment trends, products, and vendors. Users in all roles and throughout all industries contributed to provide a complete view of realities, plans, and perceptions of the market. For more information visit www.dresneradvisory.com.

About Dresner Advisory Services 
Dresner Advisory Services was formed by Howard Dresner, an independent analyst, author, lecturer, and business adviser. Dresner Advisory Services, LLC focuses on creating and sharing thought leadership for Business Intelligence (BI), Performance Management, and related areas.

Press contact:
Danielle Guinebertiere
Dresner Advisory Services
978 254 5587
[email protected]

SOURCE Dresner Advisory Services


These press releases may also interest you

at 03:30
Amflow, the eMTB expert that builds e-bikes from heart to body, today marks its entry into the industry with the launch of the Amflow PL. Providing a significantly robust 850 W of peak power and weighing in at an industry leading level of ultra-light...

at 03:17
Daniels Manufacturing Corporation® (DMC®) is proud to announce the successful acquisition of MCD-Tools GmbH, a leading tool distribution and repair company based near Frankfurt, Germany. DMC's acquisition of MCD-Tools allows DMC to form DMC Europe...

at 03:05
NielsenIQ (NIQ) today announced the availability of NIQ Activate in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. NIQ customers can now take advantage of the productive and trusted Azure cloud...

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
Manhattan Associates today announced that it has been named winner of the VIP Awards' Best Sustainability Initiative category for 2024. Selected from a competitive group of nominees, Manhattan Active® Supply Chain technology was chosen because of...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...



News published on and distributed by: